Ardena expands bioanalytical services in Europe

Ardena expands bioanalytical services in Europe


Ghent, Belgium, 29th October 2024 – Ardena
, a global CDMO that offers integrated services for drug development, is strengthening its bioanalytical services with a new laboratory and investments in Europe.

Following the recent expansion in the US, Ardena is further strengthening their capabilities with the establishment of a new bioanalytical lab at our Pivot Park facility in Oss. This along with new GLP capabilities and increased capacity at the Bioanalytical Centre of Excellence in Assen.

The new lab in Pivot Park should be operational in the first quarter of 2025 and will offer advanced analytical testing services for both small and large molecules. It will use advanced technologies such as LC-MS/MS and fluorometric detection assays, along with the ELISA-based Gyrolab automated technology platform. Ardena’s investments in Assen will strengthen capabilities in immunochemistry, flow cytometry and qPCR, while increasing LC-MS/MS capabilities and introducing new automated Hamilton systems for improved efficiency.

This strategic expansion is designed to meet the increasing demand for comprehensive and state-of-the-art bioanalytical services, allowing Ardena to offer greater flexibility in project times and faster turnaround times.

For more information, read the press release here.

Find more news here.

Pivot Park Captains' Dinner

10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.

Now it’s time to celebrate!

We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.

Erwin Wurm | Am I a House?

For the first time, the artist shows a cross-section of his work, from Narrow Furniture to One Minute Sculptures, within the walls of a historic building. Villa Constance, a former home that today houses Museum Jan Cunen, is not only a location but also part of the conversation. Because what exactly is a house?

#100YEARSPHARMAFUTURE

The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.